HAND2-AS1: A novel therapeutic target for atherosclerosis

被引：2
|
作者：
Zeng, Guang-Gui [1 ]
Li, Heng [1 ]
Tang, Chao-Ke [1 ]
机构：
[1] Univ South China, Inst Cardiovasc Dis, Grade Excellent Doctor Class Hengyang Med Coll 202, Key Lab Arteriosclerol Hunan Prov, Hengyang 421001, Hunan, Peoples R China
来源：
INTERNATIONAL JOURNAL OF CARDIOLOGY | 2022年 / 360卷
关键词：
D O I：
10.1016/j.ijcard.2022.05.045
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：76 / 76
页数：1
相关论文
共 50 条
  • [21] Oncostatin M: Risks and Benefits of a Novel Therapeutic Target for Atherosclerosis
    Rankouhi, Tanja Rouhani
    van Keulen, Danielle
    Tempel, Dennie
    Venhorst, Jennifer
    CURRENT DRUG TARGETS, 2022, 23 (14) : 1345 - 1369
  • [22] Inhibition of myeloperoxidase might be a novel therapeutic target in the treatment of atherosclerosis
    Wang, Wei
    Ren, Dong
    Wang, Chunsong
    Gong, Ying
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2018, 256 : 33 - 33
  • [23] RIP140 as a novel therapeutic target in the treatment of atherosclerosis
    Karasawa, Tadayoshi
    Takahashi, Masafumi
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2015, 81 : 136 - 138
  • [24] Apelin and APJ, a novel critical factor and therapeutic target for atherosclerosis
    Lv, Deguan
    Li, Hening
    Chen, Linxi
    ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 2013, 45 (07) : 527 - 533
  • [25] ClC-3: A Novel Promising Therapeutic Target for Atherosclerosis
    Niu, Dun
    Li, Lanfang
    Xie, Zhizhong
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2021, 26 (06) : 550 - 561
  • [26] Regulation of HAND2 Expression by LncRNA HAND2-AS1 in Ovarian Endometriosis Involving DNA Methylation
    Liu, Lingli
    Dong, Huijing
    Guan, Yining
    Fan, Tingting
    Sun, Wenxia
    Bagchi, Indrani C.
    Miao, Congxiu
    Li, Quanxi
    JOURNAL OF THE ENDOCRINE SOCIETY, 2023, 7 (06)
  • [27] ABCG1 - A potential therapeutic target for atherosclerosis
    Ni, Zhan-ling
    Zhao, Shui-ping
    Wu, Zhihong
    MEDICAL HYPOTHESES, 2007, 69 (01) : 214 - 217
  • [28] TET2 might be a therapeutic target for atherosclerosis
    Wang, Yu
    Zhao, Danyang
    Lu, Ping
    Sheng, Jing
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 203 : 396 - 397
  • [29] MD-2 as a possible therapeutic target for atherosclerosis
    Chen, Shuang
    Crother, Timothy R.
    EBIOMEDICINE, 2020, 55
  • [30] Reticulocalbin 2 as a Potential Biomarker and Therapeutic Target for Atherosclerosis
    Li, Jing
    Taylor, Angela M.
    Manichaikul, Ani
    Angle, John F.
    Shi, Weibin
    CELLS, 2022, 11 (07)
12345